Mobile Site ›
Print Friendly View

Test ID: 2D6O    
Cytochrome P450 2D6 Genotype, Saliva

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Determining the CYP2D6 genotype of patients considered for treatment with tamoxifen, psychotropic medications (such as fluoxetine, nortriptyline, paroxetine, and pimozide), codeine, and tramadol, as well as other medications metabolized by CYP2D6

Genotyping patients who prefer not to have venipuncture done

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

 

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) with Allele-Specific Primer Extension (ASPE)/Bead Hybridization with Fluorescence Detection

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

CYP2D6 Genotype, Saliva

Aliases Lists additional common names for a test, as an aid in searching

2D6
CYP
CYP2D6
Cytochrome
P450
P450 Genotyping
Treatment Resistant Depression Panel
Breast Cancer Therapy
CYP2D6 for Breast Cancer